Efficacy News and Research

RSS
New TAXUS Liberté Stent demonstrates superior results for treating long lesions

New TAXUS Liberté Stent demonstrates superior results for treating long lesions

Phase 1 extension study results of Plexxikon's PLX4032 in metastatic melanoma patients encouraging

Phase 1 extension study results of Plexxikon's PLX4032 in metastatic melanoma patients encouraging

Culligan and Good Housekeeping Seal celebrate 100th anniversary

Culligan and Good Housekeeping Seal celebrate 100th anniversary

Medifacts awarded a $1.9M contract to provide cardiac safety services

Medifacts awarded a $1.9M contract to provide cardiac safety services

Bio-Path Holdings to develop liposome tumor targeting technology

Bio-Path Holdings to develop liposome tumor targeting technology

Medtronic's transcatheter valves to be presented at TCT 2009

Medtronic's transcatheter valves to be presented at TCT 2009

Results of OASIS clinical trial reported by Cardiovascular Systems

Results of OASIS clinical trial reported by Cardiovascular Systems

Update from Advanced Cell on pre-clinical activities for its RPE cell program

Update from Advanced Cell on pre-clinical activities for its RPE cell program

Transoma Medical commences enrollment in its COMPLIANCE atrial fibrillation clinical trial

Transoma Medical commences enrollment in its COMPLIANCE atrial fibrillation clinical trial

Patient recruitment completed for crucial glioblastoma study

Patient recruitment completed for crucial glioblastoma study

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Amgen announces results of Phase 3 head-to-head trial evaluating denosumab versus Zometa

Millions of H1N1 healthcare consent forms - how to manage them?

Millions of H1N1 healthcare consent forms - how to manage them?

Three-year clinical results of  Medtronic's Resolute Zotarolimus-Eluting Coronary Stent released

Three-year clinical results of Medtronic's Resolute Zotarolimus-Eluting Coronary Stent released

New sirolimus-eluting stent shows greater neointimal suppression than PES

New sirolimus-eluting stent shows greater neointimal suppression than PES

Drug-eluting stents effective for diabetic patients

Drug-eluting stents effective for diabetic patients

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Three-year results of SPIRIT III clinical trial reaffirms safety of PROMUS and TAXUS Express stents

Researcher can anticipate immune response in Alzheimer's patients

Researcher can anticipate immune response in Alzheimer's patients

Study reveals effectiveness of drug-eluting stents in treating chronic total occlusions

Study reveals effectiveness of drug-eluting stents in treating chronic total occlusions

New device could be the solution to menstrual pain

New device could be the solution to menstrual pain

XIENCE V Everolimus Eluting Coronary Stent System exhibits its advantages over the TAXUS system

XIENCE V Everolimus Eluting Coronary Stent System exhibits its advantages over the TAXUS system

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.